Mix Sector Stocks News: Alcobra Ltd. (NASDAQ:ADHD), United States Steel (NYSE:X), Buckeye Partners, L.P. (NYSE:BPL), Nautilus (NYSE:NLS), The Babcock & Wilcox (NYSE:BWC)

Alcobra Ltd. (NASDAQ:ADHD) announced the pricing of its previously announced underwritten public offering of 6,500,000 ordinary shares at an offering price of $4 per share. Gross proceeds from the sale of the shares by Alcobra before underwriting discounts and commissions and other offering expenses are expected to be approximately $26 million. The offering is expected to close on January 14, 2015, subject to customary closing … Continue reading Mix Sector Stocks News: Alcobra Ltd. (NASDAQ:ADHD), United States Steel (NYSE:X), Buckeye Partners, L.P. (NYSE:BPL), Nautilus (NYSE:NLS), The Babcock & Wilcox (NYSE:BWC)

Don’t Miss: Ciena Corporation (NYSE:CIEN), Covenant Transportation Group, Inc. (NASDAQ:CVTI), CBOE Holdings, Inc. (NASDAQ:CBOE), Exterran Partners, L.P. (NASDAQ:EXLP), Helmerich & Payne (NYSE:HP)

Ciena Corp. (NYSE: CIEN) and Avaya are introducing an end-to-end WAN-LAN data networking solution to cost-effectively simplify network operations for enterprises while increasing control when delivering on-demand services. Combining the intelligence and simplicity of Avaya Fabric Connect technology with the programmability and scalability of Ciena’s converged packet optical and packet networking platforms, the solution provides enterprises of all sizes with a flexible architecture that can … Continue reading Don’t Miss: Ciena Corporation (NYSE:CIEN), Covenant Transportation Group, Inc. (NASDAQ:CVTI), CBOE Holdings, Inc. (NASDAQ:CBOE), Exterran Partners, L.P. (NASDAQ:EXLP), Helmerich & Payne (NYSE:HP)

St. Jude Announces Consistent Q3 Results

St. Jude Medical released third-quarter performance that was generally consistent with our expectations, and we have not altered our projections for the full year.  However, we plan to modestly raise our fair value estimate to reflect the reduced share count and cash flow realized since our last update. While St. Jude continues to wrestle with a lackluster implantable cardioverter defibrillator market, we still think the … Continue reading St. Jude Announces Consistent Q3 Results

ATMI Posts Disappointing Earnings; Revenue Drops to $100.2 Million

ATMI reported third-quarter results that were slightly below our expectations due to near-term softness in manufacturing activity in the chip industry. We are maintaining our fair value estimate and moat rating. For the quarter, revenue was $100.2 million, down 2% sequentially and down from sales of $109 million in the year-ago quarter. A near-term slowdown in semiconductor industry manufacturing activity affected demand for ATMI’s products, … Continue reading ATMI Posts Disappointing Earnings; Revenue Drops to $100.2 Million

Sonoco Results Driven by Higher Pricing and Demand

Sonoco Products announced solid third-quarter results on Thursday, driven primarily by higher overall pricing and improving demand in the Paper & Industrial Converted Products and Display Packaging segments. Management increased its full-year free cash flow (excluding dividend payments of about $129 million) target to $190 million from $150 million and tightened full-year guidance to $2.27-$2.32 per share from $2.26-$2.32 per share; we expect to leave … Continue reading Sonoco Results Driven by Higher Pricing and Demand

Roche’s Top-line Results on Track to Meet Guidance

Roche reported top-line results for the third quarter that put it on track to meet our expectations for the full year. Roche’s oncology drug portfolio and diagnostics segment form the basis of its personalized medicine strategy, feeding into the firm’s strong intangible assets and wide economic moat. At constant currencies, Roche’s sales were up 8% in the third quarter, with 9% pharmaceutical growth and 7% … Continue reading Roche’s Top-line Results on Track to Meet Guidance